Drug-induced interstitial lung disease in patients with non-small cell lung cancer treated with immunotherapy for postoperative recurrence: Evaluation of CT findings and histopathological findings of the background lung

被引：0
|
作者：
Fujimoto, S. [1 ]
Tanaka, T. [2 ]
Katsurada, N. [1 ]
Hazama, D. [1 ]
Nagano, T. [1 ]
Yamamoto, M. [1 ]
Tachihara, M. [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
549P
引用
收藏
页码：S1683 / S1684
页数：2
相关论文
共 50 条
  • [21] Severe acute interstitial lung disease after nivolumab in three non-small cell lung cancer patients with imaging findings of airway obstruction adjacent to lung tumors
    Nakahama, Kenji
    Tamiya, Akihiro
    Taniguchi, Yoshihiko
    Sasaki, Yumiko
    Akira, Masanori
    Atagi, Shinji
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2017, 23 (12) : 826 - 829
  • [22] EVALUATION OF A COMPOSITE IMMUNOTHERAPY SIGNATURE IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH ATEZOLIZUMAB
    Tolba, Khaled
    Gandara, David
    Montesion, Meagan
    Nabet, Barzin
    Srivastava, Minu
    Albacker, Lee
    Redman, Mary
    Kozono, David
    Cummings, Craig
    Herbst, Roy
    Shames, David
    Fabrizio, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A611 - A611
  • [23] Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy
    Sanchez, Alejandro
    Furberg, Helena
    JAMA ONCOLOGY, 2020, 6 (06) : 940 - +
  • [24] Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer
    Murata, Daiki
    Azuma, Koichi
    Matama, Goushi
    Zaizen, Yoshiaki
    Matsuo, Norikazu
    Murotani, Kenta
    Tokito, Takaaki
    Hoshino, Tomoaki
    THORACIC CANCER, 2023, 14 (01) : 73 - 80
  • [25] Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
    Fukuda, Kiyoko
    Katsurada, Naoko
    Kawa, Yoshitaka
    Satouchi, Miyako
    Kaneshiro, Kazumi
    Matsumoto, Masataka
    Takamiya, Rei
    Hatakeyama, Yukihisa
    Dokuni, Ryota
    Matsumura, Kanoko
    Katsurada, Masahiro
    Nakata, Kyosuke
    Yoshimura, Sho
    Tachihara, Motoko
    HELIYON, 2023, 9 (10)
  • [26] Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings
    Sakai, Fumikazu
    Johkoh, Takeshi
    Kusumoto, Masahiko
    Arakawa, Hiroaki
    Takahashi, Masahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (06) : 542 - 550
  • [27] Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings
    Fumikazu Sakai
    Takeshi Johkoh
    Masahiko Kusumoto
    Hiroaki Arakawa
    Masahiro Takahashi
    International Journal of Clinical Oncology, 2012, 17 : 542 - 550
  • [28] Postoperative Oligo-Recurrence of Non-Small Cell Lung Cancer
    Kawamata, O.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S997 - S997
  • [29] Fatal interstitial lung disease after erlotinib for non-small cell lung cancer
    Lind, Joline S. W.
    Smit, Egbert F.
    Grunberg, Katrien
    Senan, Suresh
    Lagerwaard, Frank. J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) : 1050 - 1053
  • [30] Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer
    Oi, H.
    Taniguchi, H.
    Kondoh, Y.
    Kimura, T.
    Kataoka, K.
    Matsuda, T.
    Yokoyama, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2082 - S2082
12345